Ensign Peak Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Buy |
330,911
+4,500
| +1% | +$50.6K | 0.01% | 704 |
|
|
2025
Q1 | $1.86M | Sell |
326,411
-30
| -0% | -$171 | ﹤0.01% | 926 |
|
|
2024
Q4 | $3.21M | Hold |
326,441
| – | – | 0.01% | 777 |
|
|
2024
Q3 | $2.66M | Buy |
326,441
+280,000
| +603% | +$2.28M | ﹤0.01% | 831 |
|
|
2024
Q2 | $621K | Sell |
46,441
-35
| -0.1% | -$468 | ﹤0.01% | 1535 |
|
|
2024
Q1 | $2.16M | Sell |
46,476
-2,028
| -4% | -$94.1K | ﹤0.01% | 896 |
|
|
2023
Q4 | $3.28M | Buy |
48,504
+21,044
| +77% | +$1.42M | 0.01% | 730 |
|
|
2023
Q3 | $1.99M | Sell |
27,460
-45
| -0.2% | -$3.26K | ﹤0.01% | 837 |
|
|
2023
Q2 | $2.05M | Sell |
27,505
-58,581
| -68% | -$4.36M | ﹤0.01% | 868 |
|
|
2023
Q1 | $4.58M | Sell |
86,086
-74
| -0.1% | -$3.94K | 0.01% | 598 |
|
|
2022
Q4 | $5.82M | Sell |
86,160
-7,353
| -8% | -$497K | 0.01% | 528 |
|
|
2022
Q3 | $11.7M | Hold |
93,513
| – | – | 0.03% | 354 |
|
|
2022
Q2 | $8.9M | Buy |
93,513
+7,353
| +9% | +$700K | 0.02% | 401 |
|
|
2022
Q1 | $13.9M | Sell |
86,160
-7,353
| -8% | -$1.19M | 0.03% | 358 |
|
|
2021
Q4 | $31.1M | Buy |
93,513
+91,500
| +4,545% | +$30.4M | 0.06% | 250 |
|
|
2021
Q3 | $918K | Buy |
+2,013
| New | +$918K | ﹤0.01% | 1463 |
|